1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Malignant Neoplasms: new trials by email Literature Review of Malignant Neoplasms trials Research Report on Malignant Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases Naderin, Standard Therapy - Malignant Neoplasms, Tuberculosis (TB) | Phase 2 / Phase 3 | Completed | MIPO Clinic | 75 | 2013-05-15 | 2026-06-30 |
Hepatitis C (1) · Neoplasms (1) · Neutropenia (1) · Tuberculosis (1)
Actinomycetales Infections (1) · Agranulocytosis (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Cytopenia (1) · Digestive System Diseases (1) · Flaviviridae Infections (1) · Gram-Positive Bacterial Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Infections (1)
Standard of Care (1) · sodium nucleinate (1)
MIPO Clinic (1)